NCT03513003 The Use of a Pacifier to Correct Malocclusions in Young Children
| NCT ID | NCT03513003 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Basel, Switzerland |
| Condition | Malocclusion |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2020-06-24 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2020-06-24 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the study is to investigate the effect of a pacifier (102 Medical Pacifier, Curaprox, Switzerland) on malocclusions like posterior crossbite, anterior open bite, larger overjet and tongue dysfunction in young children.
Eligibility Criteria
Inclusion Criteria: * Children who are sucking the pacifier and / or baby bottle for the last 6 months in use. * Manifesting posterior crossbite in which minium 1 tooth and/or edge to edge in the region deciduous canines and/or deciduous molars, with or without forced bite. AND / OR \- Manifesting anterior open bite in which the overbite has negative values or edge to edge (≤ 0), with or without tongue thrust. Exclusion Criteria: * Children who are thumb- or fingersucking (or sucking other objects) * syndromic or cleft patients * patients with history of cranio-facial trauma, history of temporomandibular joint infection or musculo-skeletal asymmetry (e.g. scoliosis, torticollis) * patients with systematic diseases * patients currently under or after orthodontic Treatment * patients with ankylosed teeth (e.g. after dental trauma).
Contact & Investigator
Carlalberta Verna, DDS, PhD
STUDY CHAIR
University Center for Dental Medicine, Basel, Switzerland
Frequently Asked Questions
Who can join the NCT03513003 clinical trial?
This trial is open to participants of all sexes, aged 2 Years or older, up to 5 Years, studying Malocclusion. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03513003 currently recruiting?
Yes, NCT03513003 is actively recruiting participants. Contact the research team at carlalberta.verna@unibas.ch for enrollment information.
Where is the NCT03513003 trial being conducted?
This trial is being conducted at Basel, Switzerland.
Who is sponsoring the NCT03513003 clinical trial?
NCT03513003 is sponsored by University Hospital, Basel, Switzerland. The principal investigator is Carlalberta Verna, DDS, PhD at University Center for Dental Medicine, Basel, Switzerland. The trial plans to enroll 200 participants.